PDE9 — Drug Target

All drugs that target PDE9 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Phosphodiesterase 9 (PDE9) inhibitor

Phase 3 pipeline (1)

• NI-071 · Nichi-Iko Pharmaceutical Co., Ltd. · Phosphodiesterase 9 (PDE9) inhibitor · Neurology
  NI-071 is a selective inhibitor of phosphodiesterase 9 (PDE9) that increases cyclic GMP signaling in the central nervous system.

Phase 2 pipeline (1)

• ATI-5923 · ARYx Therapeutics · Phosphodiesterase 9 (PDE9) inhibitor · Neurology
  ATI-5923 is a selective inhibitor of phosphodiesterase 9 (PDE9) that increases cyclic GMP signaling in the central nervous system.